• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症患者的社会结局不存在性别差异。

No gender differences in social outcome in patients suffering from schizophrenia.

机构信息

Department of Psychiatry, University of Naples SUN, Largo Madonna delle Grazie, 80138 Naples, Italy.

出版信息

Eur Psychiatry. 2012 Aug;27(6):406-8. doi: 10.1016/j.eurpsy.2011.01.011. Epub 2011 May 25.

DOI:10.1016/j.eurpsy.2011.01.011
PMID:21616645
Abstract

Differences between female and male patients with schizophrenia in psychopathology and course of illness have frequently been reported. However, the influence of sex on symptomatic and social remission is still an open issue. In the present study, differences between males and females in both clinical and social remission rates and in scores on several scales assessing social functioning were evaluated in 295 stabilized patients with schizophrenia, schizoaffective or delusional disorder. Female patients, as compared with males, showed a later onset of the illness, less negative symptoms and less frequent alcohol abuse. No significant difference was found between females and males in the rate of symptomatic and functional remission. No significant effect of sex was observed on any index of social functioning.

摘要

女性和男性精神分裂症患者在精神病理学和疾病过程方面的差异经常被报道。然而,性别对症状和社会缓解的影响仍然是一个悬而未决的问题。在本研究中,我们评估了 295 名稳定的精神分裂症、分裂情感障碍或妄想障碍患者的临床和社会缓解率以及评估社会功能的几个量表上的评分方面,男性和女性之间的差异。与男性相比,女性患者的发病较晚,阴性症状较少,酒精滥用较少。在症状和功能缓解率方面,女性和男性之间没有显著差异。在社会功能的任何指标上,性别都没有显著影响。

相似文献

1
No gender differences in social outcome in patients suffering from schizophrenia.精神分裂症患者的社会结局不存在性别差异。
Eur Psychiatry. 2012 Aug;27(6):406-8. doi: 10.1016/j.eurpsy.2011.01.011. Epub 2011 May 25.
2
Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.奥氮平与喹硫平治疗伴有显著阴性症状及功能障碍的精神分裂症或分裂情感性障碍患者的随机双盲6个月对照研究
J Clin Psychopharmacol. 2006 Oct;26(5):453-61. doi: 10.1097/01.jcp.0000236658.16286.25.
3
Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment.在精神分裂症中实现缓解和良好的临床功能:长期利培酮长效注射治疗最佳结局的预测因素。
Eur Psychiatry. 2010 May;25(4):220-9. doi: 10.1016/j.eurpsy.2009.09.001. Epub 2009 Nov 18.
4
Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?分裂情感性障碍的长期预后。与精神分裂症相比有哪些差异?
Riv Psichiatr. 2014 Jan-Feb;49(1):41-9. doi: 10.1708/1407.15624.
5
Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment.精神分裂症的阴性症状和社会心理功能:被忽视但重要的治疗靶点。
Eur Psychiatry. 2012 Aug;27(6):432-6. doi: 10.1016/j.eurpsy.2011.02.015. Epub 2011 May 23.
6
Treatment effectiveness in patients with schizophrenia as measured by the ASSESS battery - first longitudinal data.通过ASSESS量表评估的精神分裂症患者的治疗效果——首次纵向数据。
Psychiatr Danub. 2015 Dec;27(4):364-70.
7
Symptomatic resolution among Chinese patients with schizophrenia and associated factors.中国精神分裂症患者的症状缓解及其相关因素。
J Formos Med Assoc. 2010 May;109(5):378-88. doi: 10.1016/S0929-6646(10)60066-6.
8
The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.精神分裂症门诊患者联合药物和心理社会治疗对缓解和功能结局的有益影响。
J Psychiatr Res. 2013 Dec;47(12):1886-92. doi: 10.1016/j.jpsychires.2013.09.006. Epub 2013 Sep 19.
9
Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders.是否真正缓解?一项受精神分裂症和分裂情感障碍影响的缓解患者的研究。
Psychiatry Res. 2013 Dec 30;210(3):739-44. doi: 10.1016/j.psychres.2013.08.022. Epub 2013 Sep 3.
10
Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.功能预后缓解:精神障碍患者治疗的一个新维度。
Schizophr Res. 2007 Jul;93(1-3):160-8. doi: 10.1016/j.schres.2007.01.014. Epub 2007 Mar 28.

引用本文的文献

1
Sex differences in schizophrenia spectrum disorders: insights from the DiAPAson study using a data-driven approach.精神分裂症谱系障碍中的性别差异:来自DiAPAson研究采用数据驱动方法的见解。
Soc Psychiatry Psychiatr Epidemiol. 2025 Mar 18. doi: 10.1007/s00127-025-02855-x.
2
Characterizing multivariate regional hubs for schizophrenia classification, sex differences, and brain age estimation using explainable AI.使用可解释人工智能对精神分裂症分类、性别差异和脑龄估计的多变量区域枢纽进行特征描述。
medRxiv. 2025 Mar 4:2025.02.28.25323105. doi: 10.1101/2025.02.28.25323105.
3
Women with Schizophrenia: Beyond Psychosis.
患有精神分裂症的女性:超越精神病状态
Community Ment Health J. 2025 Jan;61(1):22-28. doi: 10.1007/s10597-024-01321-3. Epub 2024 Aug 1.
4
Brain-based sex differences in schizophrenia: A systematic review of fMRI studies.基于脑的精神分裂症中的性别差异:fMRI 研究的系统综述。
Hum Brain Mapp. 2024 Apr;45(5):e26664. doi: 10.1002/hbm.26664.
5
Sex differences in schizophrenia-spectrum diagnoses: results from a 30-year health record registry.精神分裂症谱系诊断中的性别差异:来自 30 年健康记录登记的结果。
Arch Womens Ment Health. 2024 Feb;27(1):11-20. doi: 10.1007/s00737-023-01371-8. Epub 2023 Sep 20.
6
Substance use Specificities in Women with Psychosis: A Critical Review.女性精神病患者物质使用的特异性:批判性评价。
Curr Neuropharmacol. 2023;21(9):1953-1963. doi: 10.2174/1570159X21666221129113942.
7
Gender Differences in Psychiatric Symptoms and the Social Functioning of 610 Patients with Schizophrenia in Urban China: A 10-Year Follow-Up Study.中国城市610例精神分裂症患者精神症状及社会功能的性别差异:一项10年随访研究
Neuropsychiatr Dis Treat. 2022 Jul 27;18:1545-1551. doi: 10.2147/NDT.S373923. eCollection 2022.
8
Sex Differences in Social Cognition.社会认知中的性别差异。
Curr Top Behav Neurosci. 2023;62:207-234. doi: 10.1007/7854_2022_325.
9
Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia.多基因对孤独和社会隔离与精神分裂症关系的贡献。
Nat Commun. 2022 Jan 10;13(1):51. doi: 10.1038/s41467-021-27598-6.
10
Association of Negative Symptoms of Schizophrenia Assessed by the BNSS and SNS Scales With Neuropsychological Performance: A Gender Effect.使用BNSS和SNS量表评估的精神分裂症阴性症状与神经心理表现的关联:性别效应
Front Psychiatry. 2021 Dec 24;12:797386. doi: 10.3389/fpsyt.2021.797386. eCollection 2021.